Ann: Immuron Aims to Secure FDA Approval for IMM-124E, page-13

Could be that either by design or accident Immuron have found a way to take Travelan through the FDA approval process without the need to partner or sell out to a major pharma noting that all of the various trials of IMMN 124e have basically been conducted free for Immuron by a range of bodies including the US Department of Defence.

Considering the recent filing in the US the 100 million shares at present market of .19 cents would give Immuron $19 million to spend on Travelan's promotion and FDA approval and I suspect that if they can convince the FDA to accept all of the various trial results relating to IMM 124e on behalf of Travelan this will be more than enough not forgetting that there has clearly been an increase in sales of Travelan if Amazon is anything to go by as an indicator of sales growth.

Just my opinion of course.